Amycretins unique position: Its the only molecule in late-stage development that offers both a competitive subcutaneous formulation AND a potentially game-changing oral formulation
Protein becomes non-negotiable GLP-1 medications cause weight loss
Currently, in clinical trials, it brings hope for substantial progress in weight management
Additionally, the suppression of pro-inflammatory cytokines (e.g., TNF-, IL-6) and inflammatory pathways, including the blocking of NF-B activation [39, 91], contributes to the establishment of an anti-inflammatory environment that can mitigate oxidative stress and inflammation induced muscle protein catabolism, thereby supporting the preservation of SMM and functional capacity [40]
doi:10.1146/annurev.nutr.26.061505.111223
10.1007/s13300-013-0040-0 27 DayJ